Medical treatments for incomplete miscarriage

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 1, 2017, Pages

  Kim, Caron ^a   Barnard, Sharmani ^b   Neilson, James P ^c   Hickey, Martha ^d   Vazquez, Juan C ^e   Dou, Lixia ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e INSTITUTO NACIONAL DE ENDOCRINOLOGÍA   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; ABORTIVE AGENT;

ANALGESIA; ANEMIA; BLOOD TRANSFUSION; COMPARATIVE STUDY; DIARRHEA; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEMALE FERTILITY; FETUS TISSUE; GESTATIONAL AGE; HEALTH CARE COST; HUMAN; INCOMPLETE ABORTION; LENGTH OF STAY; MATERNAL HYPERTENSION; MATERNAL MORTALITY; META ANALYSIS; NAUSEA; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT SATISFACTION; PELVIC INFLAMMATORY DISEASE; PLACENTA TISSUE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; UTERINE CERVIX DISEASE; VOMITING; ABORTION, INCOMPLETE; CHEMICALLY INDUCED; FIRST TRIMESTER PREGNANCY; FORCEPS DELIVERY; INTRAVAGINAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PREGNANCY; PROCEDURES; WATCHFUL WAITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INCOMPLETE; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; DIARRHEA; EXTRACTION, OBSTETRICAL; FEMALE; GESTATIONAL AGE; HUMANS; MISOPROSTOL; NAUSEA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VOMITING; WATCHFUL WAITING;

EID: 85011020140     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007223.pub4     Document Type: Review

References (274)

1. Bique C, Usta M, Debora B, Chong E, Westheimer E, Winikoff B. Comparison of misoprostol and manual vacuum aspiration for the treatment of incomplete abortion. International Journal of Gynecology and Obstetrics 2007;98(3):222-6. [3025836]
2. Blanchard K, Taneepanichskul S, Kiriwat O, Sirimai K, Svirirojana N, Mavimbela N, et al. Two regimens of misoprostol for treatment of incomplete abortion. Obstetrics and Gynecology 2004;103(5 Pt 1):860-5. [3025838]
3. Phupong V, Taneepanichskul S, Kriengsinyot R, Sriyirojana N, Blanchard K, Winikoff B. Comparative study between single dose 600 mg and repeated dose oral misoprostol for treatment of incomplete abortion. Contraception 2004;70:307-11. [3025839]
4. Blohm F, Friden BE, Milsom I, Platz-Christensen JJ, Nielsen S. A randomised double blind trial comparing misoprostol or placebo in the management of early miscarriage. BJOG: an international journal of obstetrics and gynaecology 2005; Vol. 112, issue 8:1090-5. [3025841]
5. Chigbu B, Onwere S, Aluka C, Kamanu C, Ezenobi O. Is misoprostol a suitable alternative to the surgical evacuation of incomplete abortion in rural South-Eastern Nigeria?. East African Medical Journal 2012;89(5):172-7. [3025843]
6. Clevin L, Munk T, Hansen TR. Spontaneous abortion. Drug treatment versus surgery [Spontan abort. Medicinsk versus kirurgisk behandling]. Ugeskrift for Laeger 2001;163(15):2136-9. [3025845]
7. Dabash R, Cherine M, Darwish E, Blum J, Hassanein N, Abdel Daiem T, et al. Bleeding following surgical (MVA) and medical (400 ug sublingual misoprostol) treatment of incomplete abortion. International Journal of Gynecology and Obstetrics 2009;107(Suppl 2):S150-1. [3025847]
8. Dabash R, Ramadan MC, Darwish E, Hassanein N, Blum J, Winikoff B. A randomized controlled trial of 400-μg sublingual misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion in two Egyptian hospitals. International Journal of Gynecology and Obstetrics 2010;111(2):131-5. [3025848]
9. Ramadan MC. Misoprostol versus MVA for incomplete abortion: results from a randomized controlled trial in Egypt. International Journal of Gynecology and Obstetrics 2009;107(Suppl 2):S68-9. [3025849]
10. Dao B, Blum J, Thieba B, Raghavan S, Ouedraego M, Lankoande J, et al. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa. BJOG: an international journal of obstetrics and gynaecology 2007;114(11):1368-75. [3025851]
11. Diop A, Raghavan S, Rakotovao JP, Comendant R, Blumenthal PD, Winikoff B. Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial. Contraception 2009;79(6):456-62. [3025853]
12. Ganguly RP, Mukhopadhyay S, Burman SK, Patra KK, Jha T, Mukherji J. A randomized trial of misoprostol compared with manual vacuum aspiration for early pregnancy failure. Nepal Journal of Obstetrics and Gynaecology 2010;5(2):8-13. [4888724]
13. Arellano M, Durocher J, Leon W, Montesinos R, Pena M, Winikoff B. Introduction of misoprostol for incomplete abortion care in Latin America: evidence from Ecuador. International Journal of Gynecology and Obstetrics 2009;107(Suppl 2):S49. [3025855]
14. Montesinos R, Durocher J, Leon W, Arellano M, Pena M, Pinto E, et al. Oral misoprostol for the management of incomplete abortion in Ecuador. International Journal of Gynecology and Obstetrics 2011;115(2):135-9. [3025856]
15. Bagratee J, Regan L, Khullar V, Moodley J, Connolly C. Does the volume of retained products of conception and hormonal parameters influence the success of conservative methods of management of first trimester miscarriage?. International Journal of Gynecology and Obstetrics 2009;107(Suppl 2):S116. [3025858]
16. Moodliar S, Bagratee JS, Moodley J. Medical vs. surgical evacuation of first-trimester spontaneous abortion. International Journal of Gynecology and Obstetrics 2005;91:21-6. [3025859]
17. Nguyen TNN, Blum J, Durocher J, Quan TTV, Winikoff B. A randomized controlled study comparing 600 versus 1, 200 micrograms oral misoprostol for medical management of incomplete abortion. Contraception 2005; Vol. 72, issue 6:438-42. [3025861]
18. Niinimaki M, Jouppila P, Martikainen H, Talvensaari-Mattila A. A randomized study comparing efficacy and patient satisfaction in medical or surgical treatment of miscarriage. Fertility and Sterility 2006;86(2):367-72. [3025863]
19. Niinimaki M, Karinen P, Hartikainen AL, Pouta A. Treating miscarriages: a randomised study of cost-effectiveness in medical or surgical choice. BJOG: an international journal of obstetrics and gynaecology 2009;116(7):984-90. [3025864]
20. Pang MW, Chung T. Incomplete miscarriage: a randomized controlled trial comparing oral with vaginal misoprostol for medical evacuation. Human Reproduction 2001;16(11):2283-7. [3025866]
21. Pang SMW, Chung TKH. A randomized clinical trial comparing oral and vaginal misoprostol for medical evacuation of spontaneous abortion [abstract]. XVI FIGO World Congress of Obstetrics and Gynecology (Book 3); 2000 Sept 3-8; Washington DC, USA. 2000:69. [3025867]
22. Paritakul P, Phupong V. Comparative study between oral and sublingual 600 μg misoprostol for the treatment of incomplete abortion. Journal of Obstetrics and Gynaecology Research 2010;36(5):978-83. [3025869]
23. Patua B, Dasgupta M, Bhattacharyya SK, Bhattacharya S, Hasan SH, Saha S. An approach to evaluate the efficacy of vaginal misoprostol administered for a rapid management of first trimester spontaneous onset incomplete abortion, in comparison to surgical curettage. Archives of Gynecology and Obstetrics 2013;288(6):1243-8. [3025871]
24. Sahin HG, Sahin HA, Kocer M. Randomized outpatient clinical trial of medical evacuation and surgical curettage in incomplete miscarriage. European Journal of Contraception & Reproductive Health Care 2001;6(3):141-4. [3025873]
25. Shelley JM, Healy D, Grover S. A randomised trial of surgical, medical and expectant management of first trimester spontaneous miscarriage. Australian and New Zealand Journal of Obstetrics and Gynaecology 2005; Vol. 45:122-7. [3025875]
26. Shochet T, Diop A, Gaye A, Nayama M, Sall AB, Bukola F, et al. Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries. BMC Pregnancy and Childbirth 2012;12:127. [3025877]
27. Shwekerela B, Kalumuna R, Kipingili R, Mashaka N, Westheimer E, Clark W, et al. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania. BJOG: an international journal of obstetrics and gynaecology 2007;114(11):1363-7. [3025879]
28. Taylor J, Diop A, Blum J, Dolo O, Winikoff B. Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana. International Journal of Gynecology and Obstetrics 2011;112(1):40-4. [3025881]
29. Petrou S, Trinder J, Brocklehurst P, Smith L. Economic evaluation of alternative management methods of first-trimester miscarriage based on results from the MIST trial. BJOG: an international journal of obstetrics and gynaecology 2006;113(8):879-89. [3025883]
30. Smith L. Extension to: randomised controlled trial of expectant, medical and surgical management of early miscarriage. www.refer.nhs.uk (accessed 7 March 2006). [3025884]
31. Smith LF, Frost J, Levitas R, Bradley H, Garcia J. Women's experiences of three early miscarriage management options: a qualitative study. British Journal of General Practice 2006;56(524):198-205. [3025885]
32. Smith LFP, Ewings PD, Quinlan C. Incidence of pregnancy after expectant, medical, or surgical management of spontaneous first trimester miscarriage: long term follow-up of miscarriage treatment (MIST) randomised controlled trial. BMJ 2009;339(1766):b3827. [3025886]
33. Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ 2006;332(7552):1235-40. [3025887]
34. Weeks A, Alia G, Blum J, Blanchard K, Winikoff B. A randomised trial of oral misoprostol (600 mcg) versus manual vacuum aspiration in the treatment of incomplete miscarriage in Kampala, Uganda. 30th British Congress of Obstetrics and Gynaecology; 2004 July 7-9; Glasgow, UK. 2004:27. [3025889]
35. Weeks A, Alia G, Blum J, Winikoff B, Ekwaru P, Durocher J, et al. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion. Obstetrics and Gynecology 2005;106(3):540-7. [3025890]
36. Chen BA, Reeves MF, Creinin MD, Gilles JM, Barnhart K, Westhoff C, et al. Misoprostol for treatment of early pregnancy failure in women with previous uterine surgery. American Journal of Obstetrics and Gynecology 2008;198(6):626.e1-5. [3025892]
37. Creinin MD, Huang X, Westhoff C, Barnhart K, Gilles JM, Zhang J, et al. Factors related to successful misoprostol treatment for early pregnancy failure. Obstetrics and Gynecology 2006;107(4):901-7. [3025893]
38. Harwood B, Nansel T, National Institute of Child Health and Human Development Management of Early Pregnancy Failure Trial. Quality of life and acceptability of medical versus surgical management of early pregnancy failure. BJOG: an international journal of obstetrics and gynaecology 2008;115(4):501-8. [3025894]
39. Reeves MF, Lohr PA, Harwood B, Creinin MD. Sonographic findings after misoprostol or vacuum aspiration for early pregnancy failure. Contraception 2006;74(2):182. [3025895]
40. Reeves MF, Lohr PA, Harwood BJ, Creinin MD. Ultrasonographic endometrial thickness after medical and surgical management of early pregnancy failure. Obstetrics and Gynecology 2008;111(1):106-12. [3025896]
41. Robledo C, Zhang J, Troendle J, Barnhart K, Creinin MD, Westhoff C, et al. Clinical indicators for success of misoprostol treatment after early pregnancy failure. International Journal of Gynecology and Obstetrics 2007;99(1):46-51. [3025897]
42. Zhang J, Gilles J, Barnhart K, Creinin M, Westhoff C, Frederick MM. Medical management with misoprostol for early pregnancy failure: a multicenter, randomized equivalence trial [abstract]. Fertility and Sterility 2004;82 Suppl 2:S53-4. [3025898]
43. Zhang J, Gilles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM, et al. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. New England Journal of Medicine 2005;353(8):761-9. [3025899]
44. Abdel Fattah IH. PGE1 analogue for the induction of midtrimester abortion in cases of intrauterine fetal death. Acta Obstetricia et Gynecologica Scandinavica Supplement 1997;76(167):26. [3025901]
45. Abd-El-Maeboud KH, Ghazy A, Ibrahim A, Hassan N, El-Bohoty A, Gamal-El-Din I. Vaginal acidity enhancement with a 3% acetic acid gel prior to misoprostol treatment for pregnancy termination in the midtrimester. International Journal of Gynecology and Obstetrics 2012;119(3):248-52. [3025903]
46. Al-Bdour AN, Akasheh H, Al-Jayousi T. Missed abortion: termination using single-dose versus two doses of vaginal misoprostol tablets. Pakistan Journal of Medical Sciences 2007;23(6):920-3. [3025905]
47. Al Inizi SA, Ezimokhai M. Vaginal misoprostol versus dinoprostone for the management of missed abortion. International Journal of Gynecology and Obstetrics 2003;83:73-4. [3025907]
48. Almog B, Levin I, Winkler N, Fainaru O, Pauzner D, Lessing JB, et al. The contribution of laminaria placement for cervical ripening in second trimester termination of pregnancy induced by intra-amniotic injection of prostaglandin f(2)alpha followed by concentrated oxytocin infusion. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2005;118:32-5. [3025909]
49. Altaf F, Sultana N, Iqbal N. Therapeutic abortions; efficacy of intra-vaginal misoprostol in comparison to extra amniotically administered prostaglandin f2a. Professional Medical Journal 2006;13(3):417-22. [3025911]
50. Amjad T, Akhtar S. Termination of pregnancy with foetal death in second trimester: Foley's catheter versus extra amniotic prostaglandins. Journal of the College of Physicians and Surgeons Pakistan 1999;9:403-5. [3025913]
51. Anderman S, Jaschevatzky OE, Ballas S. Comparison between a double balloon device and the foley catheter in extraamniotic prostaglandin F2a infusion for termination of midtrimester missed abortion [abstract]. XVI FIGO World Congress of Obstetrics and& Gynecology (Book 2); 2000 Sept 3-8; Washington DC, USA. 2000:161. [3025915]
52. Anderson J, Gouk E, Young L, Turnbull L, Sayeed G, Elattar A, et al. A randomised controlled trial of oral versus vaginal misoprostol for medical management of early fetal demise. International Journal of Gynecology and Obstetrics 2009;107(Suppl 2):S533. [3025917]
53. Ara G, Nargis S, Khatun R, Saha A. Vaginal misoprostol as a medical management in early pregnancy loss. International Journal of Gynecology and Obstetrics 2009;107(Suppl 2):S533-4. [3025919]
54. Autry A, Jacobson G, Sandhu R, Isbill K. Medical management of non-viable early first trimester pregnancy. International Journal of Gynecology and Obstetrics 1999; Vol. 67, issue 1:9-13. [3025921]
55. Avila-Vergara MA, Morgan-Ortiz F, Fragoza-Sosa O, Haro-Garcia L. Cervical labor induction with prostaglandin E2 in patients with fetal death [Maduracion cervical con prostaglandina E2 en pacientes con feto muerto]. Ginecologia y Obstetricia de Mexico 1997;65:155-8. [3025923]
56. Ayudhaya OP, Herabutya Y, Chanrachakul B, Ayuthaya NI, O-Prasertsawat P. A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial. Journal of the Medical Association of Thailand 2006;89(Suppl 4):S5-S10. [3025925]
57. Azra B, Shakeel S, Nilofer M. A comparison of two protocols of intra vaginal misoprostol for second trimester medical termination of pregnancy. Pakistan Armed Forces Medical Journal 2007;57(1):61-5. [3025927]
58. Bagratee JS, Khullar V, Regan L, Moodley J, Kagoro H. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Human Reproduction 2004;19(2):266-71. [3025929]
59. Bani-Irshaid I, Athamneh TZ, Bani-Khaled D, Al-Momani M, Dahamsheh H. Termination of second and early third trimester pregnancy: comparison of 3 methods. Eastern Mediterranean Health Journal 2006;12(5):605-9. [3025931]
60. Bebbington MW, Kent N, Lim K, Gagnon A, Delisle MF, Tessier F, et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. American Journal of Obstetrics and Gynecology 2002;187(4):853-7. [3025933]
61. Behrashi M. Comparison between the oral and vaginal misoprostol effects on pregnancy termination in second trimester. en.search.irct.ir/view/90 Date first received: 27 September 2008. [3025936]
62. Behrashi M, Mahdian M. Vaginal versus oral misoprostol for second-trimester pregnancy termination: a randomized trial. Pakistan Journal of Biological Sciences 2008;11(21):2505-8. [3025935]
63. Ben-Meir A, Erez Y, Feigenberg T, Hamani Y, Laufer N, Rojansky N. Mifepristone followed by high-dose oxytocin drip for second-trimester abortion: a randomized, double-blind, placebo-controlled, pilot study. Journal of Reproductive Medicine 2009;54(8):511-6. [3025938]
64. Biswas SC, Dey R, Jana R, Chattopadhyay N. Comparative study of intravaginal misoprostol and extra amniotic ethacridine lactate instillation for mid trimester pregnancy termination. Journal of Obstetrics and Gynaecology of India 2007;57(3):211-3. [3025942]
65. Cabrol D, Dubois C, Cronje H, Gonnet JM, Guillot M, Maria B, et al. Induction of labor with mifepristone (RU 486) in intrauterine fetal death. American Journal of Obstetrics and Gynecology 1990;163:540-2. [3025944]
66. Caliskan E, Dilbaz S, Doger E, Ozeren S, Dilbaz B. Randomized comparison of 3 misoprostol protocols for abortion induction at 13-20 weeks of gestation. Journal of Reproductive Medicine 2005;50(3):173-80. [3025946]
67. Caliskan E, Doger E, Cakiroglu Y, Corakci A, Yucesoy I. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial. European Journal of Contraception & Reproductive Health Care 2009;14(1):55-60. [3025948]
68. Chittacharoen A, Herabutya Y, Punyavachira P. A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstetrics and Gynecology 2003;101:70-3. [3025950]
69. Chung TKH, Cheung LP, Haines CJ. Spontaneous abortion: A randomized controlled trial of misoprostol versus routine surgical evacuation. Acta Obstetricia et Gynecologica Scandinavica 1997;76(167):72. [3025952]
70. Chung TKH, Cheung LP, Lee DTS, Haines CJ. Spontaneous abortion: a randomized controlled trial of misoprostol versus routine uterine curettage. British Journal of Obstetrics and Gynaecology 1998;105 Suppl 17:127. [3025953]
71. Chung TKH, Lee DTC. A randomised controlled clinical trial involving women who have aborted spontaneously: the health, social and operational cost outcomes of conservative and routine management protocols. Personal communication 1998. [3025954]
72. Chung TKH, Lee DTS, Cheung LP, Haines CJ, Chang AMZ. Spontaneous abortion: a randomised controlled trial comparing surgical evacuation with conservative management using misoprostol. Fertility and Sterility 1999;71(6):1054-9. [3025955]
73. Lee DTS, Cheung LP, Haines CJ, Chan KPM, Chung TKH. A comparison of the psychologic impact and client satisfaction of surgical treatment with medical treatment of spontaneous abortion: a randomized controlled trial. American Journal of Obstetrics and Gynecology 2001;185:953-8. [3025956]
74. Tam WH, Lau WC, Cheung LP, Yuen PM, Chung TK. Intrauterine adhesions after conservative and surgical management of spontaneous abortion. Journal of the American Association of Gynecologic Laparoscopists 2002;9(2):182-5. [3025957]
75. Tam WH, Tsui MH, Lok IH, Yip SK, Yuen PM, Chung TK. Long-term reproductive outcome subsequent to medical versus surgical treatment for miscarriage. Human Reproduction 2005;20(12):3355-9. [3025958]
76. Cleeve A, Byamugisha J, Gemzell-Danielsson K, Mbona Tumwesigye N, Atuhairwe S, Faxelid E, et al. Women's acceptability of misoprostol treatment for incomplete abortion by midwives and physicians - a randomized controlled equivalence trial at district level, Uganda. International Journal of Gynecology and Obstetrics 2015;131(Suppl 5):E295. [4888726]
77. Creinin MD, Moyer R, Guido R. Misoprostol for medical evacuation of early pregnancy failure. Obstetrics and Gynecology 1997;89:768-72. [3025960]
78. David M, Chen FCK, Lichtenegger W. NO-donor nitroglycerin versus the prostaglandin gemeprost for cervical ripening in first trimester missed abortion. International Journal of Gynecology and Obstetrics 2003;83:71-2. [3025962]
79. David M, Chen FCK. Comparison of isosorbide mononitrate (Mono Mack) and misoprostol (Cytotec) for cervical ripening in the first trimester missed abortion. Archives of Gynecology and Obstetrics 2005;273(3):144-5. [3025964]
80. de Jonge ET, Makin JD, Manefeldt E, De Wet GH, Pattinson RC. Randomised clinical trial of medical evacuation and surgical curettage for incomplete miscarriage. BMJ 1995;311(7006):662. [3025966]
81. Demetroulis C, Saridogan E, Kunde D, Naftalin AA. A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure. Human Reproduction 2001;16(2):365-9. [3025969]
82. Demetroulis C, Saridogan E, Kunde D, Naftalin AA. A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure [abstract]. XVI FIGO World Congress of Obstetrics and Gynecology (Book 3); 2000 Sept 3-8; Washington DC, USA. 2000:69. [3025968]
83. Dickinson JE, Godfrey M, Evans SF. Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial. Journal of Maternal-Fetal Medicine 1998;7:115-9. [3025971]
84. Dickinson JE, Evans SF. The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. American Journal of Obstetrics and Gynecology 2002; Vol. 186, issue 3:470-4. [3025973]
85. Dickinson JE, Evans SF. A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality. Obstetrics and Gynecology 2003;101:1294-9. [3025975]
86. Egarter C, Lederhilger J, Kurz C, Karas H, Reisenberger K. Gemeprost for first trimester missed abortion. Archives of Gynecology and Obstetrics 1995;256(1):29-32. [3025977]
87. Elhassan EM, Abubaker MS, Adam I. Sublingual compared with oral and vaginal misoprostol for termination of pregnancy with second-trimester fetal demise. International Journal of Gynecology and Obstetrics 2008;100(1):82-3. [3025979]
88. Eng NS, Guan AC. Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion. Australian and New Zealand Journal of Obstetrics and Gynaecology 1997;37(3):331-4. [3025981]
89. Eppel W, Facchinetti F, Schleussner E, Piccinini F, Pizzi C, Gruber DM, et al. Second trimester abortion using isosorbide mononitrate in addition to gemeprost compared with gemeprost alone: a double-blind randomized, placebo-controlled multicenter trial. American Journal of Obstetrics and Gynecology 2005;192:856-61. [3025983]
90. Fadalla F, Mirghani OA, Adam I. Oral misoprostol vs. vaginal misoprostol for termination of pregnancy with intrauterine fetal demise in the second-trimester. International Journal of Gynecology and Obstetrics 2004;86:52-3. [3025985]
91. Fang AH, Chen QF, Zheng W, Li YH, Chen RY. Termination of missed abortion in a combined procedure: a randomized controlled trial. Journal of Reproduction and Contraception 2009;20(1):45-9. [3025987]
92. Feldman DM, Borgida AF, Rodis JF, Leo MV, Campbell WA. A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination. American Journal of Obstetrics and Gynecology 2003; Vol. 189:710-3. [3025989]
93. Fiala C, Swahn ML, Stephansson O, Gemzell-Danielsson K. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation. Human Reproduction 2005; Vol. 20, issue 11:3072-7. [3025991]
94. Gazvani R, Templeton A. A pilot study for the use of manual vacuum aspiration in early pregnancy loss. Journal of Obstetrics and Gynaecology 2000;20(1):105. [3025993]
95. Ghorab MN, El Helw BA. Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2alpha or endocervical misoprostol A comparative study. Acta Obstetricia et Gynecologica Scandinavica 1998;77:429-32. [3025995]
96. Barnhart KT, Bader T, Huang X, Frederick MM, Timbers KA, Zhang JJ. Hormone pattern after misoprostol administration for a nonviable first-trimester gestation. Fertility and Sterility 2004;81(4):1099-105. [3025997]
97. Creinin MD, Harwood B, Guido RS, Fox MC, Zhang J, NICHD Management of Early Pregnancy Failure Trial. Endometrial thickness after misoprostol use for early pregnancy failure. International Journal of Gynecology and Obstetrics 2004;86(1):22-6. [3025998]
98. Davis AR, Robilotto CM, Westhoff CL, Forman S, Zhang J, NICHD Management of Early Pregnancy Failure Trial. Bleeding patterns after vaginal misoprostol for treatment of early pregnancy failure. Human Reproduction 2004;19(7):1655-8. [3025999]
99. Gilles J, Creinin MM, Barnhart KT, Westhoff C, Frederick MM, Zang J. Wet versus dry intravaginal misoprostol application for treatment of early pregnancy failure [abstract]. Fertility and Sterility 2002;78(3 Suppl 1):S64-5. [3026000]
100. Gilles JM, Creinin MD, Barnhart K, Westhoff C, Frederick MM, Zhang J. A randomized trial of saline solution-moistened misoprostol versus dry misoprostol for first-trimester pregnancy failure. American Journal of Obstetrics and Gynecology 2004; Vol. 190:389-94. [3026001]
101. Gonzalez JA, Carlan SJ, Alverson MW. Outpatient second trimester pregnancy termination. Contraception 2001;63(2):89-93. [3026003]
102. Graziosi G, Bruinse HW, Reuwer PJH, Teteringen O, Mol BJW. Fertility outcome after a randomized trial comparing curettage with misoprostol for treatment of early pregnancy failure. Human Reproduction 2005;20:1749-50. [3026005]
103. Graziosi GC, van der Steeg JW, Reuwer PH, Drogtrop AP, Bruinse HW, Mol BW. Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management. Human Reproduction 2005;20(4):1067-71. [3026006]
104. Graziosi GCM, Bruinse HW, Reuwer PJH, van Kessel PH, Westerweel PE, Mol BW. Misoprostol versus curettage in women with early pregnancy failure: impact on women's health-related quality life. A randomized controlled trial. Human Reproduction 2005;20(8):2340-7. [3026007]
105. Graziosi GCM, Mol BWJ, Reuwer PJH, Drogtrop A, Bruinse HW. Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. Human Reproduction 2004;19(8):1894-9. [3026008]
106. Grimes DA, Smith MS, Witham AD. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology 2005;111:148-53. [3026010]
107. Gronlund A, Gronlund L, Clevin L, Andersen B, Palmgren N, Lidegaard O. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark. Acta Obstetricia et Gynecologica Scandinavica 2002;81:1060-5. [3026012]
108. Guix C, Palacio M, Figueras F, Bennasar M, Zamora L, Coll O, et al. Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination. Fetal Diagnosis and Therapy 2005;20(6):544-8. [3026014]
109. Hassan FI, Mostapha MK, Sattar MA, Marouf E, Azim SA. Oral versus rectal route of misoprostol administration: a randomized controlled trial. Middle East Fertility Society Journal 2007;12(1):53-6. [3026016]
110. Hausler MCH, Koroschetz F, Tamussino K, Walcher W. Is a curettage after spontaneous abortion still relevant? [Ist eine currettage nach abortus completus noch zeitgemals?]. Geburtshilfe und Frauenheilkunde 1997;57:396-9. [3026018]
111. Heard MJ, Stewart GM, Buster JE, Carson SA, Miller HJ. Outpatient management of missed abortion with vaginal misoprostol [abstract]. Obstetrics and Gynecology 2002;99(4 Suppl):20S. [3026020]
112. Herabutya Y, O-Prasertsawat P. Misoprostol in the management of missed abortion. International Journal of Gynecology and Obstetrics 1997;56(3):263-6. [3026022]
113. Herabutya Y, O-Prasertsawat P. A comparison of intravaginal misoprostol with intracervical prostaglandin E2 gel for the management of dead fetus in utero. Thai Journal of Obstetrics and Gynaecology 1997; Vol. 9, issue 2:95-8. [3026024]
114. Herabutya Y, Chanrachakul B, Punyavachira P. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination. BJOG: an international journal of obstetrics and gynaecology 2005;112(9):1297-301. [3026026]
115. Hernandez-Valencia M. Cervical ripening with prostaglandin E1: how an ambulatory method decreases the hospital stay in abortus with intrauterine fetal demise. Fetal Diagnosis and Therapy 2003;18(1):54-8. [3026028]
116. Hidar S, Fekih M, Chaieb A, Bibi M, Mellouli R, Khairi H. Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea A prospective randomized trial [Apport de l'association d'ocytocine au misoprostol administre en intravaginal au cours des interruptions de grossesses entre 13 et 29 semaines d'amenorrhee. Essai clinique prospectif randomise]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 2001;30(5):439-43. [3026030]
117. Hidar S, Bouddebous M, Chaieb A, Jerbi M, Bibi M, Khairi H. Randomized controlled trial of vaginal misoprostol versus vaginal misoprostol and isosorbide dinitrate for termination of pregnancy at 13-29 weeks. Archives of Gynecology and Obstetrics 2005;273(3):157-60. [3026032]
118. Hill NCW, Selinger M, Ferguson J, MacKenzie IZ. Management of intra-uterine fetal death with vaginal administration of gemeprost or prostaglandin E2: a random allocation controlled trial. Journal of Obstetrics and Gynaecology 1991;11:422-6. [3026034]
119. Davis AR, Hendlish SK, Westhoff C, Frederick MM, Zhang J, Gilles JM, et al. Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure: results from a randomized trial. American Journal of Obstetrics and Gynecology 2007;196(1):31. [3026038]
120. Henshaw RC, Hinshaw K, Smith NC, Templeton AA. The medical management of miscarriage. Fertility Society of Australia/Australasian Gynaecological Endoscopy Society; 1995 November 19-25; Melbourne, Australia. 1995:FSA75. [3026039]
121. Hinshaw HKS. Medical management of miscarriage. In: Grundzinkas JG editor(s). Problems in Early Pregnancy - Advances in Diagnosis and Management. London: RCOG, 1997. [3026040]
122. Hinshaw K, Rispin R, Henshaw R, Smith N, Templeton A. Medical versus surgical uterine evacuation in first trimester miscarriage: a prospective, pragmatic randomised trial. 27th British Congress of Obstetrics and Gynaecology; 1995 July 4-7; Dublin, Ireland. 1995:4. [4888727]
123. Hinshaw K, Rispin R, Smith N, Templeton A. Medical vs surgical management in first trimester miscarriage: a prospective, pragmatic random allocation trial. Journal of Obstetrics and Gynaecology 1993;13(5):404-5. [3026041]
124. Hughes J, Ryan M, Hinshaw K, Henshaw R, Rispin R, Templeton A. The costs of treating miscarriage: a comparison of medical and surgical management. British Journal of Obstetrics and Gynaecology 1996;103(12):1217-21. [3026042]
125. Rispin R, Hinshaw K, Henshaw R, Smith N, Templeton A. New aspects of care in the management of miscarriage. Research in Midwifery Conference; 1993 Sept 14; Birmingham, UK. 1993. [3026043]
126. Hogg B, Owen J. Laminaria versus extraamniotic saline infusion (EASI) for cervical ripening and mid-trimester labor induction [abstract]. American Journal of Obstetrics and Gynecology 2000;182(1 Pt 2):S135. [3026045]
127. Hombalegowda RB, Samapthkumar S, Vana H, Jogi P, Ramaiah R. A randomized controlled trial comparing different doses of intravaginal misoprostol for early pregnancy failure. Contraception 2015;92(4):364-5. [4888729]
128. Igogo P, Karanja J, Kamau K, Tamooh H. Use of misoprostol for incomplete abortion in resource-poor settings. Contraception 2015;92(4):370. [4888731]
129. IRCT138902053797N1 Comparing the effects of multiple doses of misoprostol with single dose of misoprostol plus oxytocin in induction of second trimester abortion [Comparing effects of different doses of misoprostol in induction of second trimester abortion]. irct.ir/138902053797N1 (first received 12 June 2010). [3026213]
130. Islam A, Abbasi AN, Sarwar I. Use of Foley's catheter and prostaglandin F-2 alpha in second trimester termination of pregnancy. Journal of Ayub Medical College, Abbottabad 2006;18(3):35-9. [3026047]
131. Jabir M, Smeet R. Comparison of oral and vaginal misoprostol for cervical ripening before evacuation of first trimester missed miscarriage. International Journal of Gynecology and Obstetrics 2009;107(Suppl 2):S209. [3026049]
132. Jabir M, Smeet RI. Comparison of oral and vaginal misoprostol for cervical ripening before evacuation of first trimester missed miscarriage. Saudi Medical Journal 2009;30(1):82-7. [3026050]
133. Jain JK, Mishell DR. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy. New England Journal of Medicine 1994;331:290-3. [3026052]
134. Jain JK, Mishell DR. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion. American Journal of Obstetrics and Gynecology 1996;175:173-7. [3026054]
135. Jain JK, Mishell DR. A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination. Obstetrics and Gynecology 1999;93:571-5. [3026056]
136. Johnson N, Priestnall M, Marsay T, Ballard P, Watters J. A randomised trial evaluating pain and bleeding after a first trimester miscarriage treated surgically or medically. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1997;72(2):213-5. [3026058]
137. Kaluaarachchi A, Kopalakrishnan M. Surgical, medical or expectant management of first trimester miscarriage and its implications on clinical and psychological outcomes - a randomized controlled trial. Sri Lanka Journal of Obstetrics and Gynaecology 2015;37(Suppl 1):17. [4888733]
138. Kanhai HHH, Keirse MJNC. Induction of labour after fetal death: a randomized controlled trial of two prostaglandin regimens. British Journal of Obstetrics and Gynaecology 1989;96:1400-4. [3026060]
139. Kanhai HHH, Keirse MJNC. Intravenous administration of sulprostone for the induction of labour after fetal death: a randomized comparison of two dose schedules. 12th FIGO World Congress of Gynecology and Obstetrics; 1988 October 23-28; Brazil. 1988:201-2. [3026061]
140. Kanhai HHH, Keirse MJNC. Intravenous administration of sulprostone for the induction of labour after fetal death: a randomized comparison of two dose schedules. First European Congress on Prostaglandins in Reproduction; 1988 July 6-9; Vienna, Austria. 1988:45. [3026062]
141. Kapp N, Todd CS, Yadgarova KT, Alibayeva G, Nazarova D, Loza O, et al. A randomized comparison of misoprostol to intrauterine instillation of hypertonic saline plus a prostaglandin F2alpha analogue for second-trimester induction termination in Uzbekistan. Contraception 2007;76(6):461-6. [3026064]
142. Kara M, Ozden S, Eroglu M, Cetin A, Arioglu P. Comparison of misoprostol and dinoproston administration for the induction of labour in second trimester pregnancies in cases of intrauterine fetal loss. Italian Journal of Gynaecology and Obstetrics 1999;11:13-6. [3026066]
143. Klingberg-Allvin M, Cleeve A, Atuhairwe S, Mbona Tumwesigye N, Faxelid E, Byamugisha J, et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. International Journal of Gynecology and Obstetrics 2015;131(Suppl 5):E86. [4888735]
144. Klingberg-Allvin M, Cleeve A, Atuhairwe S, Tumwesigye NM, Faxelid E, Byamugisha J, et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet 2015;385(9985):2392-8. [3026068]
145. Kong GW, Lok IH, Yiu AK, Hui AS, Lai BP, Chung TK. Clinical and psychological impact after surgical, medical or expectant management of first-trimester miscarriage - a randomised controlled trial. Australian & New Zealand Journal of Obstetrics & Gynaecology 2013;53(2):170-7. [3026070]
146. Kovavisarach E, Sathapanachai U. Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum: a randomised controlled trial. Australian & New Zealand Journal of Obstetrics & Gynaecology 2002;42(2):161-3. [3026072]
147. Kovavisarach E, Jamnansiri C. Intravaginal misoprostol 600 ug and 800 ug for the treatment of early pregnancy failure. International Journal of Gynecology and Obstetrics 2005;90(3):208-12. [3026074]
148. Kushwah B, Singh A. Sublingual versus oral misoprostol for uterine evacuation following early pregnancy failure. International Journal of Gynecology and Obstetrics 2009;106(1):43-5. [3026076]
149. Kushwah DS, Kushwah B, Salman MT, Verma VK. Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise. Indian Journal of Pharmacology 2011;43(3):306-10. [3026078]
150. Lelaidier C, Baton-Saint-Mleux C, Fernandez H, Bourget P, Frydman R. Mifepristone (RU486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial. Human Reproduction 1993;8(3):492-5. [3026080]
151. Lippert TH, Luthi A. Induction of labour with prostaglandin E2 gel in cases of intrauterine fetal death. Prostaglandins 1978;15:533-42. [3026082]
152. Lister MS, Shaffer LET, Bell JG, Lutter KQ, Moorma KH. Randomized, double-blind, placebo-controlled trial of vaginal misoprostol for management of early pregnancy failures. American Journal of Obstetrics and Gynecology 2005;193:1338-43. [3026084]
153. Louey K. Misoprostol for the medical management of miscarriage (ongoing trial). Personal communication 2000. [3026086]
154. Lu PH, Lu J, Zou S. Comparisons of the effects of misoprostol by two different application on the treatment of missed abortion. Chinese Journal of Pharmaceutical Biotechnology 2014;21(2):159-61. [3026088]
155. Lughmani ST. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of 1st trimester pregnancy. BJOG: an international journal of obstetrics and gynaecology 2008;115(s1):179. [3026092]
156. Lughmani ST. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of 1st trimester pregnancy. Double blind randomized trial [abstract]. 31st British International Congress of Obstetrics and Gynaecology; 2007 July 4-6; London, UK. 2007:209. [4888736]
157. Machtinger R, Stockheim D, Goldenberg M, Soriano D, Atlas M, Seidman DS. A randomized prospective study of misoprostol alone or combined with mifepristone for treatment of first trimester spontaneous abortion [abstract]. Fertility and Sterility 2002; Vol. 78, issue 3 Suppl 1:S64. [3026094]
158. Machtinger R, Stockheim D, Shulman A, Dulitzki M, Schiff E, Seidman DS. A randomized prospective study comparing the effectiveness of four protocols for treatment of first trimester spontaneous abortion [abstract]. Fertility and Sterility 2004;82 Suppl 2:S80. [3026095]
159. Makhlouf AM, Al-Hussaini TK, Habib DM, Makarem MH. Second-trimester pregnancy termination: comparison of three different methods. Journal of Obstetrics and Gynaecology 2003;23:407-11. [3026097]
160. Martin RH, Menzies DN. Oestrogen therapy in missed abortion and labour. Journal of Obstetrics and Gynaecology of the British Commonwealth 1955;62:256-8. [3026099]
161. Moran T, Deutsch R. Methotrexate/misoprostol vs. a more standard approach for termination of pregnancies of undetermined location: a randomized, controlled trial. Journal of Reproductive Medicine 2005;50(10):784-92. [3026101]
162. Mostafa-Gharebaghi P, Mansourfar M, Sadeghi-Bazargani H. Low dose vaginal misoprostol versus prostaglandin E2 suppository for early uterine evacuation: a randomized clinical trial. Pakistan Journal of Biological Sciences 2010;13(19):946-50. [3026103]
163. Muffley PE, Stitely ML, Gherman RB. Early intrauterine pregnancy failure: a randomized trial of medical versus surgical treatment. American Journal of Obstetrics and Gynecology 2002;187:321-6. [3026105]
164. Mulayim B, Celik NY, Onalan G, Zeyneloglu HB, Kuscu E. Sublingual misoprostol after surgical management of early termination of pregnancy. Fertility and Sterility 2009;92(2):678-81. [3026107]
165. Nakintu N. A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour in women with intra uterine fetal death in Mulago Hospital, Uganda. African Health Sciences 2001;1(2):55-9. [3026109]
166. Nasreen Z. What for early pregnancy failure manual vacuum aspiration (MVA) with small dose misoprostol or misoprostol alone?. International Journal of Gynecology and Obstetrics 2009;107(Suppl 2):S539-40. [3026111]
167. NCT00141895 A randomized trial of two regimens of misoprostol for second trimester termination for intrauterine fetal death. clinicaltrials.gov/ct2/show/NCT00141895 (first received 1 September 2005). [3026113]
168. NCT00190294 Expectant versus immediate medical management for the evacuation of the nonevolutives pregnancies before 13 GW. clinicaltrials.gov/ct2/show/NCT00190294 (first received 12 September 2005). [3026155]
169. NCT00468299 MiMi: a randomized trial of mifepristone and misoprostol for treatment of early pregnancy failure. clinicaltrials.gov/show/NCT00468299 (first received 1 May 2007). [3025940]
170. Ng BK, Annamalai R, Lim PS, Aqmar Suraya S, Nur Azurah AG, Muhammad Abdul Jamil MY. Outpatient versus inpatient intravaginal misoprostol for the treatment of first trimester incomplete miscarriage: a randomised controlled trial. Archives of Gynecology and Obstetrics 2015;291:105-13. [3026115]
171. Ngai SW, Chan YM, Tang OS, Ho PC. Vaginal misoprostol as medical treatment for first trimester spontaneous miscarriage. Human Reproduction 2001;16(7):1493-6. [3026117]
172. Ngoc NTN, Blum J, Westheimer E, Quan TV, Winikoff B. Medical treatment of missed abortion using misoprostol. International Journal of Gynecology and Obstetrics 2004;87:138-42. [3026119]
173. Nielsen S, Hahlin M, Platz-Christensen J. Expectant management or pharmacological treatment for first trimester spontaneous abortion: a randomised trial. Acta Obstetricia et Gynecologica Scandinavica 1997; Vol. 76, issue 167:77. [3026121]
174. Nielsen S, Hahlin M, Platz-Christensen J. Randomised trial comparing expectant with medical management for first trimester miscarriages. British Journal of Obstetrics and Gynaecology 1999;106(8):804-7. [3026122]
175. Niromanesh S, Hashemi-Fesharaki M, Mosavi-Jarrahi A. Second trimester abortion using intravaginal misoprostol. International Journal of Gynecology and Obstetrics 2005;89:276-7. [3026124]
176. Nor Azlin MI, Abdullah HS, Zainul Rashid MR, Jamil MA. Misoprostol (alone) in second trimester terminations of pregnancy: as effective as Gemeprost?. Journal of Obstetrics and Gynaecology 2006;26(6):546-9. [3026126]
177. Nuthalapaty F, Ramsey P, Biggio J, Owen J. Comparative efficacy of high dose vaginal misoprostol for mid-trimester labor induction [abstract]. American Journal of Obstetrics and Gynecology 2004;191(6 Suppl 1):S73. [3026128]
178. Nuthalapaty FS, Ramsey PS, Biggio JR, Owen JO. High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial. American Journal of Obstetrics and Gynecology 2005;193:1065-70. [3026129]
179. Nuutila M, Toivonen J, Ylikorkala O, Halmesmaki E. A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion. Obstetrics and Gynecology 1997;90(6):896-900. [3026131]
180. Owen J, Hauth JC. Vaginal misoprostol vs. concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination. Journal of Maternal-Fetal Medicine 1999;8(2):48-50. [3026133]
181. Pansky M, Fuchs N, Ben AI, Tovbin Y, Halperin R, Vaknin Z, et al. Intercoat (Oxiplex/AP Gel) for preventing intrauterine adhesions following operative hysteroscopy for suspected retained products of conception - A pilot study. Journal of Minimally Invasive Gynecology 2011;18(6 Suppl 1):S21. [3026135]
182. Paraskevaides E, Prendiville W, Stuart B, Scanaill SN, Walsh D, McGuinness N, et al. Medical evacuation of first trimester (twelve weeks gestation) incomplete abortion and missed abortion. Journal of Gynecologic Surgery 1992;8(3):159-63. [3026137]
183. Perry KG, Rinehart BK, Terrone DA, Martin RW, May WL, Roberts WE. Second-trimester uterine evacuation: a comparison of intra-amniotic (15S)-15-methyl-prostaglandin F2alpha and intravaginal misoprostol. American Journal of Obstetrics and Gynecology 1999;181:1057-61. [3026139]
184. Petersen SG, Perkins A, Gibbons K, Bertolone J, Devenish-Meares P, Cave D, et al. Can we use a lower intravaginal dose of misoprostol in the medical management of miscarriage? A randomised controlled study. Australian & New Zealand Journal of Obstetrics & Gynaecology 2013;53(1):64-73. [3026141]
185. Piotrowski J, Basta A, Klimczyk K, Malolepazy A, Dluzniewska M, Splawinski JA. Indomethacin increases abortifacient effect of PGE2 in man. Prostaglandins 1979;17:451-9. [3026143]
186. Pongsatha S, Tongsong T. Intravaginal misoprostol for pregnancy termination. International Journal of Gynecology and Obstetrics 2004;87:176-7. [3026145]
187. Ramsey PS, Savage K, Lincoln T, Owen J. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction. Obstetrics and Gynecology 2004;104(1):138-45. [3026147]
188. Rausch M, Lorch S, Chung K, Frederick M, Zhang J, Barnhart K. A cost-effectiveness analysis of surgical versus medical management of early pregnancy loss. Fertility and Sterility 2012;97(2):355-60.e1. [3026149]
189. Rita Gupta S, Kumar S. A randomised comparison of oral and vaginal misoprostol for medical management of first trimester missed abortion. JK Science 2006;8(1):35-8. [3026151]
190. Rivero-Lopez E, Marquez-Maraver F, Duenas-Diez JL, Cabezas-Sanchez B. Deferred miscarriage: effectiveness of intravaginal misoprostol versus laminaria stems [Aborto diferido: eficacia del misoprostol intravaginal versus la aplicación de tallos de laminaria]. Progresos de Obstetricia y Ginecologia 1998;41:579-81. [3026153]
191. Roy G, Ferreira E, Hudon L, Marquette G. The efficacy of oral versus vaginal misoprostol for second-trimester termination of pregnancy: a double-blind, randomized, placebo controlled trial [abstract]. American Journal of Obstetrics and Gynecology 2003;189(6 Suppl 1):S70. [3026157]
192. Ruangchainikhom W, Phongphissanou E, Bhekasuta J, Sarapak S. Effectiveness of 400 or 600 micrograms of vaginal misoprostol for terminations of early pregnancies. Journal of the Medical Association of Thailand 2006;89(7):928-33. [3026159]
193. Saichua C, Phupong V. A randomized controlled trial comparing powdery sublingual misoprostol and sublingual misoprostol tablet for management of embryonic death or anembryonic pregnancy. Archives of Gynecology and Obstetrics 2009;280(3):431-5. [3026161]
194. Salamalekis E, Loghis C, Kassanos D, Traka A, Zourlas PA. Comparison of extra-amniotic prostaglandin F2alpha and dinoprostone use for labor induction after second trimester intrauterine fetal death. 12th European Congress of Perinatal Medicine; 1990 Sept 11-14; Lyon, France. 1990:228. [3026163]
195. Sathapanachai U. Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum. Thai Journal of Obstetrics and Gynaecology 2000;12(4):363. [3026165]
196. Shah N, Azam SI, Khan NH. Sublingual versus vaginal misoprostol in the management of missed miscarriage. JPMA - Journal of the Pakistan Medical Association 2010;60(2):113-6. [3026167]
197. Shaikh ZAN. Comparison between misoprostol alone and misoprostol with manual vacuum aspiration for the treatment of missed and incomplete miscarriage. BJOG: an international journal of obstetrics and gynaecology 2008;115(s1):83. [3026169]
198. Shobeira JM, Atashkhoii S. Second trimester pregnancy termination by intravaginal and parenteral form of prostaglandin E2 [abstract]. 31st British International Congress of Obstetrics and Gynaecology; 2007 July 4-6; London, UK. 2007:210. [3026171]
199. Shokry M, Shahin AY, Fathalla MM, Shaaban OM. Oral misoprostol reduces vaginal bleeding following surgical evacuation for first trimester spontaneous abortion. International Journal of Gynecology and Obstetrics 2009;107(2):117-20. [3026173]
200. Shuaib AA, Alharazi AH. Medical versus surgical termination of the first trimester missed miscarriage. Alexandria Journal of Medicine 2013;49:13-6. [3026175]
201. Sonsanoh A, Chullapram T. Comparison of sublingual and vaginal misoprostol for termination of early pregnancy failure: a randomized controlled trial. Thai Journal of Obstetrics and Gynaecology 2014;22(3):128-36. [3026177]
202. Sripramote M, Chatsuphang W. A randomized comparison of oral and vaginal misoprostol for cervical priming before uterine curettage in the first trimester of pregnancy. Vajira Medical Journal 2000;44(3):207-15. [3026179]
203. Stockheim D, Machtinger R, Wiser A, Dulitzky M, Soriano D, Goldenberg M, et al. A randomized prospective study of misoprostol or mifepristone followed by misoprostol when needed for the treatment of women with early pregnancy failure. Fertility and Sterility 2006; Vol. 86, issue 4:956-60. [3026181]
204. Su L-L, Biswas A, Choolani M, Kalaichelvan V, Singh K. A prospective, randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy. American Journal of Obstetrics and Gynecology 2005;193:1410-4. [3026183]
205. Suchonwanit P. Comparative study between vaginal misoprostol 200 mg and 400 mg in first trimester intrauterine fetal death and anembryonic gestation. Thai Journal of Obstetrics and Gynaecology 1999;11(4):263. [3026185]
206. Surita FGC. Misoprostol versus laminaria for cervical ripening in intrauterine fetal death. Acta Obstetricia et Gynecologica Scandinavica Supplement 1997;76(167):32. [3026187]
207. Tang OS, Lau WNT, Ng EHY, Lee SWH, Ho PCH. A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriage. Human Reproduction 2003;18(1):176-81. [3026189]
208. Tang OS, Ong CY, Tse KY, Ng EH, Lee SW, Ho PC. A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage. Human Reproduction 2006;21(1):189-92. [3026191]
209. Tanha FD. Comparison of the efficacy of two routes of misoprostol administration (sublingual and vaginal) for termination of second trimester pregnancy. en.search.irct.ir/view/1614 Date first received: 28 November 2010. [4888737]
210. Tanha FD, Feizi M, Shariat M. Sublingual versus vaginal misoprostol for the management of missed abortion. Journal of Obstetrics and Gynaecology Research 2010;36(3):525-32. [3026195]
211. Thavarasah AS, Almohdzar SA. Prostaglandin (F2 alpha) in missed abortion Intravenous, extra-amniotic and intramuscular administration--a randomized study. Biological Research in Pregnancy and Perinatology 1986;7:106-10. [3026197]
212. Thida M, Shwe MM, Htun KT, Maung NM, Khine EP, Win KSM, et al. A randomised clinical trial comparing different routes of administration of repeated doses of 400ug misoprostol for management of missed miscarriages and anembryonic gestations in North Okkalapa General Hospital, Yangon, Myanmar. BJOG: an international journal of obstetrics and gynaecology 2015;122(Suppl S1):26-7. [4888739]
213. Toppozada MK, Shaala SA, Anwar MY, Haiba NA, Abdrabbo S, El-Absy HM. Termination of pregnancy with fetal death in the second and third trimesters - the double balloon versus extra-amniotic prostaglandin. International Journal of Gynecology and Obstetrics 1994;45:269-73. [3026199]
214. Torre A, Huchon C, Bussieres L, Machevin E, Camus E, Fauconnier A. Immediate versus delayed medical treatment for first-trimester miscarriage: a randomized trial. American Journal of Obstetrics and Gynecology 2012;206(3):215.e1-6. [3026201]
215. Wood SL, Brain PH. Medical management of missed abortion: a randomized clinical trial. Obstetrics and Gynecology 2002;99(4):563-6. [3026203]
216. Yapar EG, Senoz S, Urkutur M, Batioglu S, Gokmen O. Second trimester pregnancy termination including fetal death: comparison of five different methods. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1996;69:97-102. [3026205]
217. Yilmaz B, Kelekci S, Ertas IE, Kahyaoglu S, Ozel M, Sut N, et al. Misoprostol moistened with acetic acid or saline for second trimester pregnancy termination: a randomized prospective double-blind trial. Human Reproduction 2005;20(11):3067-71. [3026207]
218. Yilmaz B, Kelekci S, Ertas IE, Ozel M, Sut N, Mollamahmutoglu L, et al. Randomized comparison of second trimester pregnancy termination utilizing saline moistened or dry misoprostol. Archives of Gynecology and Obstetrics 2007;276(5):511-6. [3026209]
219. Yu X H. Clinical observation of 42 cases of mifepristone and Misoprostol in missed abortion. Journal of Chinese Medical Writing 2000;7(5):552-3. [3026211]
220. Zhang C, Cheng W. A contrastive analysis of the efficacy of misoprostol and li fan nuo in intermediate term of pregnancy. Journal of Wuhan University of Science and Technology (Natural Science Edition) 2000;23(4):409-11. [3026215]
221. ISRCTN65305620 Is misoprostol a safe alternative to manual vacuum aspiration in women with early pregnancy failure in a low resource setting?. www.isrctn.com/ISRCTN65305620 (first received 1 February 2008). [3026217]
222. NCT01033903 Which is the optimal treatment for miscarriage with a gestational sac in the uterus and which factors can predict if the treatment will be successful? [Optimal treatment of miscarriage]. clinicaltrials.gov/show/NCT01033903 (first received 16 December 2009). [3026219]
223. Aleman A, Althabe F, Belizán J, Bergel E. Bed rest during pregnancy for preventing miscarriage. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD003576.pub2]
224. Alfirevic Z, Alfaifel N, Weeks A. Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews 2014, Issue 6. [DOI: 10.1002/14651858.CD001338.pub3]
225. Ankum WM, Wieringa-de Waard M, Bindels PJE. Management of spontaneous miscarriage in the first trimester: an example of putting informed shared decision making into practice. BMJ 2001;322:1343-6.
226. Arthur P, Taggart MJ, Mitchell BF. Oxytocin and parturition: a role for increased myometrial calcium and calcium sensitization?. Frontiers in Bioscience 2007;12:619-33.
227. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2008;328(7454):1490.
228. Balogun O, da Silva Lopes K, Ota E, Takemoto Y, Rumbold A, Takegata M, et al. Vitamin supplementation for preventing miscarriage. Cochrane Database of Systematic Reviews 2016, Issue 5. [DOI: 10.1002/14651858.CD004073.pub4]
229. Bamigboye AA, Morris J. Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD004353]
230. Calvache JA, Delgado-Noguera MF, Lesaffre E, Stolker RJ. Anaesthesia for evacuation of incomplete miscarriage. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD008681.pub2]
231. Chung TKH, Cheung LP, Leung TY, Haines CJ, Chang AMZ. Misoprostol in the management of spontaneous abortion. British Journal of Obstetrics and Gynaecology 1995;102:832-5.
232. Costa SH, Vessey MP. Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet 1993;341:1258-61.
233. de Jong PG, Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database of Systematic Reviews 2014, Issue 7. [DOI: 10.1002/14651858.CD004734.pub4]
234. Dodd JM, Crowther CA. Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD004901]
235. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD002859.pub2]
236. Fonseca W, Alencar AJC, Mota FSB, Coelho HLL. Misoprostol and congenital malformations. Lancet 1991;338:56.
237. Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database of Systematic Reviews 2013, Issue 10. [DOI: 10.1002/14651858.CD003511.pub3]
238. Harris LH, Dalton VK, Johnson TRB. Surgical management of early pregnancy failure: history, politics, and safe, cost-effective care. American Journal of Obstetrics and Gynecology 2007;196(5):445.e1-5.
239. Harwood B, Nansel T, the National Institute of Child Health and Human Development Management of Early Pregnancy Failure Trial. Quality of life and acceptability of medical versus surgical management of early pregnancy failure. BJOG: an international journal of obstetrics and gynaecology 2008;115(4):501-8.
240. Hawk HW, Conley HH. Effect of prostaglandin F2 alpha, phenylephrine and ergonovine on uterine contractions in the ewe. Journal of Animal Science 1985;60(2):537-43.
241. Higgins JP, Green S, editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
242. Hofmeyr GJ, Gülmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD000941]
243. Jain JK, Dutton C, Harwood B, Meckstroth KR, Mishell DR Jr. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Human Reproduction 2002;17(6):1477-82.
244. Kawarabayashi T, Kishikawa T, Sugimori H. Effect of methylergometrine maleate (methergin) on electrical and mechanical activities of pregnant human myometrium. Gynecologic and Obstetric Investigation 1990;24(4):246-9.
245. Klier CM, Geller PA, Ritsher JB. Affective disorders in the aftermath of miscarriage: a comprehensive review. Archives of Women's Mental Health 2002;5:129-49.
246. Kulier R, Kapp N, Gülmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. Medical methods for first trimester abortion. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD002855.pub3]
247. Lewis G, editor The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving mothers' lives: reviewing maternal deaths to make motherhood safer - 2003-2005. The seventh report on confidential enquiries into maternal deaths in the United Kingdom. London: CEMACH, 2007.
248. Lohr PA, Hayes JL, Gemzell-Danielsson K. Surgical versus medical methods for second trimester induced abortion. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD006714.pub2]
249. Lok IH, Neugebauer R. Psychological morbidity following miscarriage. Best Practice & Research. Clinical Obstetrics & Gynaecology 2007;21(2):229-47.
250. Luise C, Jermy K, May C, Costello G, Collins WP, Bourne TH. Outcome of expectant management of spontaneous first trimester miscarriage: observational study. BMJ 2002;324:873-5.
251. Mota-Rojas D, Villanueva-García D, Velazquez-Armenta EY, Nava-Ocampo AA, Ramírez-Necoechea R, Alonso-Spilsbury M, et al. Influence of time at which oxytocin is administered during labor on uterine activity and perinatal death in pigs. Biological Research 2007;40(1):55-63.
252. Murphy FA, Lipp A, Powles DL. Follow-up for improving psychological well being for women after a miscarriage. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD008679.pub2]
253. Nanda K, Lopez LM, Grimes DA, Peloggia A, Nanda G. Expectant care versus surgical treatment for miscarriage. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD003518.pub3]
254. Neilson JP, Hickey M, Vazquez J. Medical treatment for early fetal death (less than 24 weeks). Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD002253.pub3]
255. Norman JE, Thong KJ, Baird DT. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 1991;338:1233-6.
256. Ramphal SR, Moodley J. Emergency gynaecology. Best Practice & Research. Clinical Obstetrics & Gynaecology 2006;20(5):729-50.
257. Royal College of Obstetricians and Gynaecologists. The Management of Early Pregnancy Loss. Royal College of Obstetricians and Gynaecologists, Guideline No. 25. London: RCOG, 2006.
258. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
259. Sawyer E, Ofuasia E, Ofili-Yebovi D, Helmy S, Gonzalez J, Jurkovic D. The value of measuring endometrial thickness and volume on transvaginal ultrasound scan for the diagnosis of incomplete miscarriage. Ultrasound in Obstetrics & Gynecology 2007;29(2):205-9.
260. Say L, Brahmi D, Kulier R, Campana A, Gülmezoglu M. Medical versus surgical methods for first trimester termination of pregnancy. Cochrane Database of Systematic Reviews 2010, Issue 3. [DOI: 10.1002/14651858.CD003037.pub2]
261. Shiers C. Abnormalities of early pregnancy. In: Fraser DM, Cooper MA editor(s). Myles Textbook for Midwives. 14th Edition. Edinburgh: Churchill Livingstone, 2003.
262. Smith LFP, Ewings PD, Quinlan C. Incidence of pregnancy after expectant, medical, or surgical management of spontaneous first trimester miscarriage: long term follow-up of miscarriage treatment (MIST) randomised controlled trial. BMJ 2009;339(1766):b3827.
263. Swanson KM. Effects of caring, measurement, and time on miscarriage impact and women's well-being. Nursing Research 1999;48(6):288-98.
264. Tang OS, Ho PC. The use of misoprostol for early pregnancy failure. Current Opinion in Obstetrics and Gynecology 2006;18(6):581-6.
265. Thapar AK, Thapar A. Psychological sequelae of miscarriage: a controlled study using the general health questionnaire and the hospital anxiety and depression scale. British Journal of General Practice 1992;42(356):94-6.
266. Tuncalp O, Gülmezoglu AM, Souza JP. Surgical procedures for evacuating incomplete miscarriage. Cochrane Database of Systematic Reviews 2010, Issue 9. [DOI: 10.1002/14651858.CD001993.pub2]
267. Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD000494.pub4]
268. Weeks A, Alia G. Ultrasonography may have role in assessing spontaneous miscarriage. BMJ 2001;323:694.
269. Wildschut HIJ, Both MI, Medema S, Thomee E, Wildhagen MF, Kapp N. Medical methods for mid-trimester termination of pregnancy. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/14651858.CD005216.pub2]
270. Wong LF, Porter TF, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD000112.pub3]
271. Zieman M, Fong SK, Benowitz NL, Bankster D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstetrics and Gynecology 1997;90:88-92.
272. Neilson JP, Gyte GML, Hickey M, Vazquez JC. Medical treatments for incomplete miscarriage (less than 24 weeks). Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD007223]
273. Neilson JP, Gyte GML, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage (less than 24 weeks). Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD007223.pub2]
274. Neilson JP, Gyte GML, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database of Systematic Reviews 2013, Issue 3. [DOI: 10.1002/14651858.CD007223.pub3]